Joint Formulary & PAD

Ondansetron hydrochloride - Nausea and vomiting (chemotherapy induced)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Oral solution reserved for use when tablets are not suitable. On request from the specialist / Cancer Centre
 

Status 2

Blue
Formulations :
  • Oro-dispersible
  • Orodispersible films
Associated Icons :
Restrictions / Comments :
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable. On request from the specialist / Cancer Centre
 

Status 3

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ondansetron hydrochloride
Indication :
Nausea and vomiting (chemotherapy induced)
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Ondansetron hydrochloride is used to treat.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.